DJIA 18,258.96 126.26 0.70%
NASDAQ 5,000.52 37.00 0.75%
S&P 500 2,115.95 11.45 0.54%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

58.59 0.05 (0.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $58.60 0.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.29
Previous Close $58.54
Daily Range $58.28 - $58.89
52-Week Range $52.49 - $63.62
Market Cap $167.0B
P/E Ratio 14.38
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,423,444
Average Daily Volume 10,063,632
Current FY EPS $3.41




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

Billionaire George Soros Just Dumped These 3 Dividend Stocks

Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?

Merck’s Partnership With NGM Is A Bold Move

Fast Money Picks For March 2

This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed

Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?

Which Cancer Immunotherapy Will Be the Most Successful?

Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.

Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog

Dow Jones (DJIA) Today: Merck (MRK) Lower

Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers

Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN

A Quick Review Of The Asthma Market

See More MRK News...

MRK's Top Competitors

MRK $58.59 (0.08%)
Current stock: MRK
JNJ $103.25 (0.72%)
Current stock: JNJ
NVS $100.17 (0.16%)
Current stock: NVS
RHHBY $33.96 (-0.51%)
Current stock: RHHBY